Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-12.88 Mil
% of Total Estimate Gain
-59.31%

SAMSARA BIOCAPITAL, LLC's Climb Bio Inc Holding Summary

As of 2025-03-31, SAMSARA BIOCAPITAL, LLC held - shares of Climb Bio Inc(CLYM), totaling N/A. This investment constitutes 0% of their stock portfolio, and SAMSARA BIOCAPITAL, LLC now holds 0% of the outstanding Climb Bio Inc(CLYM) stock.

The initial trade took place in 2024Q2. And since then SAMSARA BIOCAPITAL, LLC has made 1 purchases of CLYM, at an average price of $6.66, for a total of 3.26 Mil shares. In addition, there have been 2 sales at an average price of $2.71 for 3.26 Mil shares. Based on historical transaction data and CLYM's current price of $1.35, SAMSARA BIOCAPITAL, LLC's estimated gain on his CLYM holdings is $-12.88 Mil, reflecting a -59.31% gain to date.

SAMSARA BIOCAPITAL, LLC CLYM ($1.35) Holding Chart

SAMSARA BIOCAPITAL, LLC CLYM ($1.35) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1